Lab Impact on Cancer Diagnosis and Treatment with Biomarker Tests
Focused particularly on NSCLC and Melanoma, a discussion on the huge shift towards biomarker testing for targeted therapies and immunotherapies.
Recent posts
5-year Progress in Digital Pathology
A retrospective over 5 years and prognosis for digital pathology.
FDA approves first T-cell therapy for a solid tumor
Using a tumor derived immunotherapy composed of a patient’s own disease-fighting white blood cells known as T-cells - specific type called tumor-infiltrating...
Data Scientist layoff: How to handle it?
Some real great and timely wisdom on what to do proactively and reactively!
The worlds she sees - Prof. Fei-Fei Li
The fascinating personal journey of one of the pioneers of visual AI. From immigrant beginnings to “CEO” of a laundromat to Professor at Stanford. Plus, the ...